Drug Shortage Report for TEVA-MELOXICAM

Last updated on 2020-10-15 History
Report ID 126522
Drug Identification Number 02258315
Brand name TEVA-MELOXICAM
Common or Proper name MELOXICAM 7.5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MELOXICAM
Strength(s) 7.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30UD & 100's Bot
ATC code M01AC
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-14
Estimated end date 2020-11-30
Actual end date
Shortage status Actual shortage
Updated date 2020-10-15
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-10-15 French Compare
v1 2020-10-15 English Compare